Age-related macular degeneration, or AMD, is the leading cause of vision loss among seniors, gradually eroding crucial central vision

WASHINGTON — An experimental drug is showing promise against an untreatable eye disease that blinds older adults — and intriguingly, it seems to work in patients who carry a particular gene flaw that fuels the damage to their vision.

\uc870\ucee4 \ud3ec\ucee4 5PK \uce74\uc9c0\ub178\uba38\uc2e0\u3001\uc2ac\ub86f\uba38\uc2e0 \uc885\ub958 \u2013 esball \uc804\uc790\uac8c\uc784Age-related macular degeneration, or AMD, is the leading cause of vision loss among seniors, gradually eroding crucial central vision. There are different forms but more than 5 million people worldwide, and a million in the U.S., have an advanced type of so-called “dry” macular degeneration that has no treatment. At first patients may notice blurriness when they look straight ahead. Eventually many develop blank spots, becoming legally blind.

“These are seniors who are entering their golden years and now they’ve lost the ability to read, watch television, see their loved ones,” said Dr. Rahul Khurana, a retina specialist and spokesman for the American Academy of Ophthalmology.

The experimental drug, lampalizumab, aims to slow the destruction of light-sensing cells in the retina, creeping lesions that characterize the stage of dry AMD called “geographic atrophy.” When those cells die, they can’t grow back — the vision loss is irreversible.

In an 18-month study of 129 patients, monthly eye injections of the drug modestly slowed worsening of the disease when compared with patients given dummy shots. What’s exciting for scientists came next, when researchers from drugmaker Genentech Inc. took a closer look at exactly who was being helped.

It turns out that nearly 6 in 10 of the study’s participants carry a gene variation that makes part of the immune system go awry – a genetic flaw already known to increase the risk of getting macular degeneration in the first place.

Those are the only patients who appeared to benefit from the drug; they had 44 percent less eye damage than the untreated patients, the Genentech team reported Wednesday in the journal Science Translational Medicine. While the study is too small to prove if lampalizumab really helps maintain vision, that’s a bigger difference than the overall results suggested.

One arm of the immune system, the complement pathway, helps fight infections by attracting immune cells to attack bacteria.

Normally, there’s a barrier that keeps such cells away from the retina. But that barrier can break down with age, opening sensitive eye cells to harm from the spillover, explained Genentech immunologist Menno van Lookeren Campagne.

Now for the gene connection: Previous studies have linked macular degeneration to gene variations that remove some of that pathway’s natural brakes, so it can become too active.

The hypothesis: Genentech’s drug, lampalizumab, 먹튀 없는 토토 essentially offers a backup method for tamping down the immune reaction. An antibody, it works by inhibiting a particular enzyme named factor D that helps power the immune pathway.

“We try to reinsert the braking ability,” said study lead author Brian Yaspan, a Genentech senior scientist.

Wednesday’s study detected no safety concerns, clearing the way for Genentech and its parent company Roche to open two large-scale studies that aim to prove if the drug works. Results are expected later this year.

The current research sheds light on how that long-suspected immune culprit might be working, and is “the first suggestion that there may be a treatment for geographic atrophy coming up in the future,” said National Eye Institute retina specialist Dr. Wai Wong, who wasn’t involved in the study.

“It’s a very, very exciting study,” said Khurana, the ophthalmologist association’s spokesman, who also wasn’t part of the research. “From the basic science perspective, it makes a lot of sense.”

Macular degeneration tends to occur after age 60, but it sometimes strikes earlier. According to the National Eye Institute, it’s less common in people who exercise regularly, avoid smoking, and eat a diet high in green leafy vegetables and fish.

Symptoms often aren’t noticeable early on. But several eye tests can detect signs of macular degeneration, including a dilated eye exam and a tool called an Amsler grid with straight lines that may look wavy if the macula, the center of the retina, is harmed.

Macular degeneration patients often are advised to take certain vitamin combinations that may help stave off advanced disease. And it’s important for patients to know what type they have. While there’s no treatment for the advanced dry form, the “wet” form occurs when leaky blood vessels grow under the retina — and there are several therapies that can help those patients preserve vision.

Related Posts

A NATO diplomat said there was no discussion of speeding up the 2014 timeline during the meeting between Karzai and the alliance chief. The diplomat, who spoke on condition of anonymity in line with alliance’s regulations, said Karzai was eager to see the next stage of transition, which would have Afghan forces take charge of security for almost the entire country. More in Afghanistan: The way forward There are questions, however, about the ability of the Afghan forces to secure the country. The Afghan army has grown to 184,676 soldiers, and the country’s police force now numbers 146,339 officers – putting them just short of the planned number of 352,000 members. But critics say the rapid expansion has not significantly improved their ability to plan and conduct operations without support from foreign forces in terms of logistics, air support and medical evacuations. Furthermore, the number of Afghans leaving the army has remained stubbornly high, with 27 percent of troops either deserting or not re-enlisting despite the higher salaries offered. And though the number of volunteers is still high, the army needs to train about 50,000 recruits each year just to compensate for the loss. Polls show that the 11-year war has little public support among NATO’s 28 member states, most of which are cutting defense budgets as part of the austerity measures adopted to deal with the financial crises. A recent upsurge in the number of insider attacks on coalition troops by Afghan soldiers or police – or insurgents disguised in their uniforms – has further undermined public support for the war in the West. At least 52 American and other NATO troops have died so far this year in those attacks. In the past several months, there have been calls in the United States and elsewhere to accelerate the drawdown and to withdraw coalition troops by the end of next year. Fogh Rasmussen said the alliance remains committed to help enable Afghan forces assume full responsibility for the country’s security after 2014. The military alliance has also agreed to offer a smaller, post-2014 mission to help Afghan forces with training, advice and assistance. “We are committed to continuing that cooperation with the Afghan national security forces,” he said. The secretary-general and NATO’s governing body, the North Atlantic Council, were visiting Kabul Thursday for meetings with Karzai, coalition military commander Gen. John Allen and commanders of Afghan government forces. The current strategy agreed to by NATO, its partners and Karzai’s government is to enable the Afghans to take over the war against the Taliban and other insurgents by the end of 2014. NATO started drawing down its forces earlier this year. It currently has 104,000 troops in Afghanistan – 68,000 of them Americans – down from 140,000 the alliance had here in 2011. Among those who left are the 33,000 U.S. troops deployed to Afghanistan after 2009, when President Barack Obama ordered a surge in a bid to quell the Taliban. Karzai also said he did not believe the outcome of the upcoming presidential elections in the United States would affect Washington’s long-term policy toward Afghanistan regardless of whether President Barack Obama or his Republican challenger, Mitt Romney, emerges as the winner. “America has a set strategy for Afghanistan and any government who comes in will follow that, so it will not affect Afghanistan,” Karzai said.
Hours after his arrest, Bangladeshi detectives were at his family’s three-story home in the Jatrabari neighborhood in south Dhaka
I wrote the book, then, to persuade people of two things: that violence has, contrary to appearances, come down, and that this can be explained by the struggle among our inner demons and our better angels.

No comments

Leave a Reply

Your email address will not be published. Required fields are marked *